Projecten per jaar
Persoonlijk profiel
Expertise
- Research for therapies, targeting the myeloma cell in its microenvironment
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
-
SRP84: SRP-Onderzoekszwaartepunt: PACT: multi-omics Profilering van T-cellen om Adoptieve Cel Therapie te verbeteren
Vanderkerken, K., Breckpot, K. & Menu, E.
1/11/22 → 31/10/27
Project: Fundamenteel
-
OZR3983: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, TU Chenggong
7/07/22 → 6/07/26
Project: Fundamenteel
-
OZR3593: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - NPU, WANG Fang
22/06/20 → 21/06/24
Project: Fundamenteel
-
OZR3565: Seahorse platform: de Agilent Seahorse Flux Analyser met geïntegreerd normalizatie systeem
Massie, A., Stiens, J., Van Ginderachter, J., Vanommeslaeghe, K., Vinken, M., Menu, E., Spits, C. & Njemini, R.
1/05/20 → 30/04/24
Project: Fundamenteel
Onderzoeksoutput
-
Elevated LAG-3 expression in plasma cells and lymphoid subpopulations at distinct stages of Multiple Myeloma disease progression
Satilmis, H., Vandewalle, N., Verheye, E., Fan, R., De Bruyne, E., Menu, E., Devoogdt, N., Vanderkerken, K., Breckpot, K. & De Veirman, K., 29 sep 2023, (Unpublished).Onderzoeksoutput: Poster
-
Hypoxic bone marrow stromal cells secrete miR-140-5p and miR-28-3p target SPRED1 to confer drug resistance in multiple myeloma
Zhang, H., Du, Z., Tu, C., Zhou, X., Menu, E. & Wang, J., 26 sep 2023, (E-pub ahead of print) In: Cancer Research. 49 blz., 23-0189.Onderzoeksoutput: Article › peer review
-
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis
Van der Vreken, A., Oudaert, I., Ates, G., Faict, S., Vlummens, P., Satilmis, H., Fan, R., Maes, A., Massie, A., De Veirman, K., De Bruyne, E., Vanderkerken, K. & Menu, E., 28 mrt 2023, In: Journal of pathology. 260, 2, blz. 112-123 12 blz.Onderzoeksoutput: Article › peer review
1 Citaat (Scopus) -
PYCR1 inhibition in multiple myeloma-associated stromal cells limits tumor growth.
Oudaert, I. & Menu, E., 14 apr 2023.Onderzoeksoutput: Poster
-
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma
Wang, Y., Muylaert, C., Wyns, A., Vlummens, P., De Veirman, K., Vanderkerken, K., Zaal, E., Berkers, C., Moreaux, J., De Bruyne, E. & Menu, E., 20 jul 2023, (E-pub ahead of print) In: Haematologica.Onderzoeksoutput: Article › peer review
Prijzen
-
-
Best Oral Presentation - MOSA conference 2021
Janssens, E. M. (Recipient), De Beck, Lien (Recipient), Verbeke, R. (Recipient), Lentacker, I. (Recipient), Dewitte, H. (Recipient), Menu, Eline (Recipient) & Breckpot, Karine (Recipient), 23 jun 2021
Prijs: Prize (including medals and awards)
Bestand -
Hitting multiple myeloma cells from multiple angles using Galsome vaccination and immune checkpoint inhibition
Breckpot, Karine (Recipient) & Menu, Eline (Recipient), 15 dec 2019
Prijs: Fellowship awarded competitively
-
TARGETING MONOCARBOXYLATE TRANSPORTER 4 REDUCES MYELOMA CELL VIABILITY IN VITRO
Oudaert, Inge (Recipient), Menu, Eline (Recipient) & Van Droogenbroeck, Lauren (Recipient), 3 mrt 2021
Prijs: Prize (including medals and awards)
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Oudaert, Inge (Recipient) & Menu, Eline (Recipient), 29 jan 2021
Prijs: Prize (including medals and awards)
Activiteiten
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Speaker), Eline Menu (Contributor) & Kim De Veirman (Contributor)
29 jan 2021 → 30 jan 2021Activiteit: Talk or presentation at a conference
-
TARGETING MONOCARBOXYLATE TRANSPORTER 4 REDUCES MYELOMA CELL VIABILITY IN VITRO
Inge Oudaert (Contributor), Eline Menu (Presenter) & Lauren Van Droogenbroeck (Presenter)
3 mrt 2021 → 6 mrt 2021Activiteit: Talk or presentation at a conference
-
Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
Inge Oudaert (Speaker) & Eline Menu (Speaker)
29 jan 2021Activiteit: Talk or presentation at a conference
Bestand -
Granted Project Scientific Fund Willy Gepts: Hitting multiple myeloma cells from multiple angles using Galsome vaccination and immune checkpoint inhibition
Karine Breckpot (Supervisor), Eline Menu (Supervisor) & Heleen Dewitte (Supervisor)
1 jan 2020 → 1 jan 2024Activiteit: Other